Dr. Mouen A Khashab, MD

Claim this profile

Johns Hopkins Hospital

Studies Cancer
Studies Gastric Outlet Obstruction
2 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
Johns Hopkins Hospital
Image of trial facility.
The Johns Hopkins Hospital

Clinical Trials Mouen A Khashab, MD is currently running

Image of trial facility.

POEM-F

for Achalasia

Per-oral endoscopic myotomy (POEM) has emerged as the endoscopic treatment of choice for achalasia, offering comparable symptom relief with laparoscopic Heller's cardiomyotomy. The main concern with POEM is the higher incidence of post-procedure gastroesophageal reflux disease (GERD), occurring in up to 50-60% of patients. In order to reduce the risk of GERD, endoscopic fundoplication has been developed as a novel procedure mimicking surgical anterior partial fundoplication that can be performed in the same session as POEM (POEM-F). Case series of POEM-F in patients with achalasia reported encouraging outcomes of low GERD rate of \~12% at 1 year. Prospective comparative data between POEM-F and conventional POEM on post-procedure GERD is current lacking. The investigators therefore designed an international multicenter prospective randomized study to investigate the efficacy of POEM-F. The investigators postulate that POEM-F could reduce the incidence of post-procedure GERD when compared with conventional POEM. This is an international multicenter randomized controlled trial conducted between high volume expert centers from Hong Kong SAR, China, India and United States of America. Adult patients with manometry confirmed achalasia would be randomised to undergo POEM-F or POEM. The procedure would be performed by experts with vast experience in POEM. The primary outcome is the incidence of post-procedure GERD at 1 year, defined by the updated Lyon consensus. Secondary outcomes include technical and clinical success rates, adverse events, post-POEM endoscopic and manometry findings as well as patients' symptom scores. Sample size calculation Based on existing pilot comparative data on POEM-F and POEM, it is estimated that 84 patients would be required to demonstrate a difference in post-procedure GERD of 47.6% to 18.2%, with 80% power and false positive rate of 0.05, accounting for 10% loss to follow-up. Purpose and potential The current study proposal could demonstrate the superiority of POEM-F over POEM in reducing post-procedural GERD. It would also demonstrate the safety and reproducibility of the technique in expert centers across the globe. It could potentially replace conventional POEM as the preferred minimally invasive endoscopic treatment for achalasia.
Recruiting1 award N/A3 criteria

More about Mouen A Khashab, MD

Clinical Trial Related5 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Mouen A Khashab, MD has experience with
  • Lumen-apposing Metal Stent
  • Self-expandable Metal Stent
  • Conventional POEM
  • POEM-F

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Mouen A Khashab, MD specialize in?
Is Mouen A Khashab, MD currently recruiting for clinical trials?
Are there any treatments that Mouen A Khashab, MD has studied deeply?
What is the best way to schedule an appointment with Mouen A Khashab, MD?
What is the office address of Mouen A Khashab, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security